Open original FDA record ↗Recall record
- FDA identifier
- Z-2756-2026
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Jul 20, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can be mitigated by inserting the dilator straight through the center of the valve and fully advancing it into the sheath body.
Source facts
- Action
- An Important Medical Device Product Advisory notification letter dated 6/11/26 was sent to customers. Actions " Follow the revised IFU provided in Appendix 1. " Forward this notice to relevant personnel and any facilities to which the product was transferred. " Complete and return the enclosed Acknowledgement Form. " Report any adverse events or quality concerns associated with use of these devices to Boston Scientific via email at BSCComplaints@bsci.com or FDA s MedWatch Adverse Event Reporting program [www.fda.gov/MedWatch/report.htm or 1.800.FDA.1088 (332.1088)]. If you require additional assistance or more information regarding this communication, please contact your local Boston Scientific representative.
- Initiated
- 2026-06-11
- Root cause
- Use error
- Distribution
- Global Distribution. US Nationwide.
- Recall number
- Z-2756-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221152
- FDA classified
- 2026-07-20
- Recall event number
- 99252